Coupland Cardiff Asset Management LLP - WUXI PHARMATECH CAYMAN INC ownership

Quarter-by-quarter ownership
Coupland Cardiff Asset Management LLP ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$1,944,000
-16.4%
45,000
-18.2%
6.29%
+8.2%
Q2 2015$2,324,000
-75.2%
55,000
-77.2%
5.81%
-72.2%
Q1 2015$9,353,000
-38.0%
241,186
-46.2%
20.89%
-1.1%
Q4 2014$15,096,000
-4.1%
448,361
-0.2%
21.12%
+34.9%
Q3 2014$15,737,000
+83.2%
449,361
+71.9%
15.66%
+128.1%
Q2 2014$8,588,000
-10.9%
261,3610.0%6.86%
+2.5%
Q1 2014$9,634,000
-76.2%
261,361
-75.2%
6.70%
-75.9%
Q4 2013$40,491,000
+203.2%
1,055,000
+116.5%
27.81%
-25.2%
Q3 2013$13,355,000487,40037.16%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,762,017$64,948,0007.10%
Coupland Cardiff Asset Management LLP 261,361$9,634,0006.70%
Sloane Robinson LLP 160,100$5,901,0003.50%
Myriad Asset Management Ltd. 418,728$15,434,0003.07%
Granite Point Capital Management, L.P. 102,000$3,760,0002.69%
GRATRY & Co LLC 191,545$7,060,0002.54%
Consonance Capital Management LP 430,889$15,883,0002.36%
Grandeur Peak Global Advisors, LLC 263,135$9,699,0002.29%
Mirae Asset Global Investments Co., Ltd. 2,356,378$86,856,0002.20%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 91,460$3,371,0001.60%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders